For the Inventor, By the Inventor

Enter assignee name

Boonton, NJ, United States of America

Enteris Biopharma, Inc.

USPTO Granted Patents = 13

CIPO Patents = 16

EPO Patents = 7

Trademarks = 3

Forward Citations = 57

Loading Chart...

Loading Chart...

34 inventors (with patents filed for the assignee):

William Stern (8 out of 30 patents)

Angelo P Consalvo (6 out of 21 patents)

John Vrettos (4 out of 4 patents)

4. Thomas A Daggs (3 out of 3 patents)

5. Paul P Shields (3 out of 3 patents)

6. Nozer M Mehta (3 out of 37 patents)

7. Stephen M Carl (3 out of 3 patents)

8. James P Gilligan (3 out of 24 patents)

9. Aniruddha M Railkar (2 out of 2 patents)

10. George R Maurer (2 out of 2 patents)

11. Phillip Bauer (2 out of 2 patents)

12. Raymundo Claudio (1 out of 1 patent)

13. Martha V L Ray (1 out of 10 patents)

14. Christopher P Meenan (1 out of 11 patents)

15. Duncan A Miller (1 out of 1 patent)

13 patents: Sort by Forward Citations

1. 11998640 - Room temperature stable oral calcitonin formulation (2024-06-04),

2. 11285113 - Room temperature stable oral calcitonin formulation (2022-03-29),

3. 9833411 - Solid oral dosage forms (2017-12-05),

4. 9744140 - Pharmaceuticals for oral delivery (2017-08-29),

5. 9526785 - Pharmaceuticals for oral delivery (2016-12-27),

6. 9504727 - Oral delivery of peptide pharmaceutical compositions (2016-11-29),

7. 9457086 - Pharmaceuticals for oral delivery (2016-10-04),

8. 9399017 - Peptide pharmaceutical for oral delivery (2016-07-26),

9. 8835161 - Bacterial host cell for the direct expression of peptides (2014-09-16),

10. 8815583 - Cell lines for expressing enzyme useful in the preparation of amidated products (2014-08-26),

11. 8664178 - Peptide pharmaceutical for oral delivery (2014-03-04),

12. 8592366 - Peptide pharmaceutical for oral delivery (2013-11-26),

13. 8513183 - Peptide pharmaceutical for oral delivery (2013-08-20),

Enteris BioPharma, Inc. is a biotechnology company specializing in oral drug delivery solutions. They develop innovative products that improve the bioavailability and therapeutic outcomes of drugs. With a proprietary technology platform, Enteris offers formulation development and manufacturing services to pharmaceutical partners. Their goal is to advance clinical assets and deliver effective oral therapies for patients in need.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

13 Patents

#5 in Boonton, NJ

#889 in New Jersey

#23,099 in US

#43,615 in the World

Boonton, NJ, United States of America

Enteris Biopharma, Inc.

Forward Citations = 57

34 inventors:

William Stern (8 out of 30 patents)

Angelo P Consalvo (6 out of 21 patents)

John Vrettos (4 out of 4 patents)

4. Thomas A Daggs (3 out of 3 patents)

5. Paul P Shields (3 out of 3 patents)

Please report any incorrect information to support@idiyas.com

Loading…